Anthravax®

For the active immunisation of cattle, sheep and goats against Anthrax.

FOR ANIMAL USE ONLY

ANTHRAVAX®

Reg. No. G2064 (Act 36/1947)

Namibia Reg. No. V95/24.4/495 NS0

Anthrax is a controlled disease in terms of the animal diseases act (Act 35/1984). The occurrence or suspicion of the disease must be reported to the responsible State Veterinarian immediately.

INDICATIONS

For the active immunisation of cattle, sheep and goats against anthrax.

COMPOSITION

Contains a suspension of live spores of uncapsulated avirulent strain (Sterne 34F2) of Bacillus anthracis.

STORAGE INSTRUCTIONS

Store between 2 °C – 8 °C in a refrigerator.

Do not freeze.

Protect from light.

WARNINGS

  • Withdrawal period: Do not slaughter animals for human consumption within 21 days after vaccination.
  • Since the immune response to the anthrax component depends on multiplication of the living organisms after injection, the administration of antibacterial drugs should be avoided wherever possible from shortly before and until 2 weeks after vaccination.
  • Goats should be vaccinated in the loose skin underneath the tail. Do not vaccinate goats in the neck.
  • As with all vaccines occasional hypersensitivity reactions may occur. In such cases consult a veterinarian.
  • Usually, no marked reaction follows vaccination, although a transient swelling may appear at the site of inoculation and an animal may show a rise of temperature for 1 or 2 days.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

  • Observe aseptic precautions. Ensure that vaccination equipment (needles, syringes, etc.) is clean and sterile prior to and during use.
  • Partially used containers should be disposed of at the end of each day’s operation since under field conditions, it may be difficult to avoid accidental contamination of the vaccine.
  • Destroy any unused vaccine and dispose of all the empty vaccine containers and disposable equipment after use in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008).

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

The bottle should be shaken well before doses are withdrawn.

DOSAGE          

Cattle: 1 mℓ via subcutaneous (SC) injection.

Sheep: 0,5 mℓ via subcutaneous (SC) injection.

Goats: 0,5 mℓ via subcutaneous (SC) injection in the loose skin under the tail.

Animals should first be vaccinated at 3 to 6 months of age and annually thereafter.

In areas where animals are likely to be subjected to continued exposure to infection, vaccination every 6 months may be advisable.

Under normal conditions, annual revaccination will usually suffice.

PREGNANCY AND LACTATION

Can be used during pregnancy and lactation.

PRESENTATION

100 mℓ Polypropylene vials capped with synthetic rubber stopper and aluminium seals packed in an outer cardboard container (Cattle – 100 doses, Sheep and goats – 200 doses).

REGISTRATION HOLDER     

Intervet South Africa (Pty) Ltd.         

20 Spartan Road, Spartan     

1619, RSA        

Tel: +27 (0) 11 923 9300         

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT

15 May 2006

Zimbabwe Reg. No. 88/80.23.10/9224
Pharmacological Classification: 80.23.10 vaccines
Category for Distribution: VMGD